//
Angie Mae Rodday
Susan K Parsons
Carlton Scharman
Ranjana Advani
Massimo Federico
Jonathan W. Friedberg
Andrea Gallamini
David C. Hodgson
Peter Hoskin
Martin Hutchings
Peter Johnson
Kara M. Kelly
Brian K. Link
John A. Radford
Pier Luigi Zinzani
James R. Cerhan
John Raemaekers
Andrew M. Evens
Institute for Clinical Research and Health Policy Studies, Tufts Medical Center, Boston, MA
Tufts Medical Center, Tufts University School of Medicine, Boston, MA
Division of Oncology, Department of Medicine, Saul A. Rosenberg Professor of Lymphoma, Stanford Cancer Institute, Stanford, CA
CHIMOMO department, Università degli Studi di Modena e Reggio Emilia, Modena, Italy
Division of Endocrinology, University of Rochester, Rochester, NY
Research Innovation and Statistics, Antoine-Lacassagne Cancer Centre, Nice, France
Department of Medical Imaging, Princess Margaret Cancer Centre, University Health Network, Toronto, ON, Canada
Mount Vernon Hospital, London, GBR
Department of Hematology; Finsen Centre, National Hospital, Copenhagen University Hospital, Copenhagen, Denmark
Southampton General Hospital School of Medicine, Southampton, United Kingdom
Department of Medicine, Roswell Park Comprehensive Cancer Center, Buffalo, NY
Division of Hematology, Oncology and Blood & Marrow Transplantation, University of Iowa Hospitals and Clinics, Iowa City, IA
The University of Manchester and the Christie NHS Foundation Trust, Manchester Academic Health Science Centre, Manchester, United Kingdom
Istituto di Ematologia "Seràgnoli", Dipartimento di Medicina Specialistica, Diagnostica e Sperimentale, Università degli Studi, Bologna, Italy
Division of Medical Oncology, Mayo Clinic, Rochester, MN
Radboud University Medical Center, Njmegen, Netherlands
Rutgers Cancer Institute of New Jersey, New Brunswick, NJ
United States
Italy
France
Canada
Denmark
United Kingdom
N/A
Oncology (ONC)
Hodgkin's Lymphoma
Solid malignancies
Estrogen receptor alpha
Human albumin
White Blood Cell
HD0801
N/A
Multinational
Prospective
NA
N/A
N/A
N/A